Log in

MCET MULTICELL TECHNOLOGIES INC OTC · United States

MULTICELL TECHNOLOGIES INC (MCET) news

MULTICELL TECHNOLOGIES INC is a public biotech or pharmaceutical company listed on OTC under the ticker MCET, recorded under United States. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest MULTICELL TECHNOLOGIES INC news

We have not published a story on MULTICELL TECHNOLOGIES INC yet. When there is news, it will appear here.

Questions about MULTICELL TECHNOLOGIES INC

What is the ticker symbol of MULTICELL TECHNOLOGIES INC?

MULTICELL TECHNOLOGIES INC trades under the ticker MCET on OTC.

Where is MULTICELL TECHNOLOGIES INC listed?

MULTICELL TECHNOLOGIES INC is listed on OTC.

Which country or territory is MULTICELL TECHNOLOGIES INC listed under?

Our directory records MULTICELL TECHNOLOGIES INC under United States.

What does MULTICELL TECHNOLOGIES INC do?

Our directory classifies MULTICELL TECHNOLOGIES INC as: Biotechnology. This is a directory classification, not a description of the pipeline.

What is the ISIN of MULTICELL TECHNOLOGIES INC?

The ISIN recorded for MULTICELL TECHNOLOGIES INC is US62544S2005.

Does aibio.space cover MULTICELL TECHNOLOGIES INC?

aibio.space lists MULTICELL TECHNOLOGIES INC among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to MULTICELL TECHNOLOGIES INC?

Companies in our directory listed in the same country and business area as MULTICELL TECHNOLOGIES INC: Apimeds Pharmaceuticals US, ADARx Pharmaceuticals, Voyager Therapeutics, Oncotelic Therapeutics, BioVie, Traws Pharma.

Investor discussion: MULTICELL TECHNOLOGIES INC

Members talk about MULTICELL TECHNOLOGIES INC (MCET). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open OTC:MCET on TradingView.

Listing details

MULTICELL TECHNOLOGIES INC is a public biotech or pharmaceutical company listed on OTC under the ticker MCET, recorded under United States. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
MULTICELL TECHNOLOGIES INC
Ticker
MCET
Listing
OTC
Country or territory
United States
Business scope
Biotechnology
ISIN
US62544S2005
Last quote in directory
2026-10-21
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.